Related Experiment Videos
[Treatment of aspiration pneumonia with piperacillin]
J P Ducroix1, A Tondriaux, A Smail
1Service de Médecine Interne E, CHR Nord, Amiens.
Abstract:
Clinical efficacy and safety of piperacillin were evaluated in 30 patients with a severe aspiration pneumonia admitted in our intensive care unit from july 1987 to december 1988. 20 women and 10 men (with a mean SAPS: 14) had a right pneumonia in 17 cases, left in 6, bilateral in 7 cases. A pathogen was isolated in 18 patients by protected distal catheterism, in 3 patients by blood cultures. 25 patients cured. However with a high isolation of Staphylococci it appears reasonable to associate piperacillin with an aminoglycoside before the obtention of bacteriological results.
Insights
Piperacillin demonstrated clinical efficacy in treating severe aspiration pneumonia in intensive care unit patients. Combination therapy with an aminoglycoside is recommended due to high Staphylococcus isolation rates.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pharmacology
Context:
- Severe aspiration pneumonia presents a significant challenge in intensive care settings.
- Bacterial pathogens, including Staphylococcus, are frequently implicated in severe pneumonia.
- Piperacillin is a commonly used antibiotic for bacterial infections.
Purpose:
- To evaluate the clinical efficacy and safety of piperacillin in patients with severe aspiration pneumonia.
- To identify common pathogens and assess treatment outcomes.
- To inform antibiotic treatment strategies for this patient population.
Summary:
- A study assessed piperacillin in 30 intensive care unit patients with severe aspiration pneumonia.
- Pathogens were identified in 18 patients; 25 patients achieved cure.
- High rates of Staphylococcus isolation suggest combining piperacillin with an aminoglycoside.
Impact:
- Findings support the use of piperacillin for severe aspiration pneumonia.
- The study highlights the importance of considering combination therapy based on likely pathogens.
- Results contribute to evidence-based guidelines for managing severe pneumonia in critical care.